Overview and Scope
Inactivated vaccines, also known as killed vaccines, are a type of vaccine that contains viruses or bacteria that have been killed or inactivated using heat, chemicals, or radiation. These vaccines are designed to stimulate an immune response without causing disease in the vaccinated individual.
Sizing and Forecast
The inactivated vaccines market size has grown steadily in recent years. It will grow from $5.95 billion in 2023 to $6.19 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to polio eradication efforts, influenza vaccination programs, emerging infectious diseases, regulatory approvals.
The inactivated vaccines market size is expected to see steady growth in the next few years. It will grow to $7.33 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine coverage, biomanufacturing advancements, health equity initiatives. Major trends in the forecast period include mrna vaccine platforms, combination vaccines, thermostable vaccines, digital vaccine passports.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Segmentation & Regional Insights
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine; Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent; Radiation; pH Concentration; Heat Inactivation; Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Other Distribution Channels
Top Major Players:
Pfizer Inc.
Johnson & Johnson Services Inc.
Sinopharm Group Co. Ltd.
Merck & Co. Inc.
Sanofi S.A
North America was the largest region in the inactivated vaccines market in 2023.
North America was the largest region in the inactivated vaccines market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of infectious diseases is expected to propel the growth of the inactivated vaccine market going forward. Infectious diseases are illnesses caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread from person to person, resulting in a wide range of symptoms and health complications. Tuberculosis is one type of infectious disease. Inactivated vaccines use non-living pathogens to stimulate an immune response, effectively preventing diseases like polio, hepatitis A and influenza. For instance, in October 2022, according to the Global Tuberculosis Report published by the World Health Organization, a Switzerland-based global health agency, there will be a 4.5% increase in the global incidence of tuberculosis from the projected 10.1 million cases to 10.6 million cases in 2021. The majority of tuberculosis cases were reported in the Southeast Asia region, accounting for 45% of the total, followed by Africa with 23% of the cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the inactivated vaccine market.
Key Industry Players
Major players in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .
The inactivated vaccines market report table of contents includes:
1. Executive Summary
2. Inactivated Vaccines Market Characteristics
3. Inactivated Vaccines Market Trends And Strategies
4. Inactivated Vaccines Market - Macro Economic Scenario
5. Global Inactivated Vaccines Market Size and Growth
….
32. Global Inactivated Vaccines Market Competitive Benchmarking
33. Global Inactivated Vaccines Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Inactivated Vaccines Market
35.Inactivated Vaccines Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Get FREE Sample Report Before Buying @ https://www.upmarketresearch.com/home/requested_sample/5056 UpMarketResearch offers a latest published report on “Global Veterinary Vaccine Market Analysis and Forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 154 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.
The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Region-wise Analysis Global Veterinary Vaccine Market covers:North AmericaEuropeChinaJapanIndiaSoutheast AsiaOther regions (Central & South America, Middle East & Africa) The Major players reported in the market include:CevaElanco/Eli LillySindh Poultry Vaccine CentreBio-LabsVaksindo For More Information, Please Visit @ https://www.upmarketresearch.com/home/enquiry_before_buying/5056 Global Veterinary Vaccine Market: Product Segment Analysis:Live Attenuated VaccinesInactivated VaccinesDNA VaccinesOther Global Veterinary Vaccine Market: Application Segment Analysis:LivestockSwineChickenDogCatOther The Report covers in-depth analysis as follows:Chapter 1 Overview of Veterinary VaccineChapter 2 Global Market Status and Forecast by RegionsChapter 3 Global Market Status and Forecast by TypesChapter 4 Global Market Status and Forecast by Downstream IndustryChapter 5 Market Driving Factor Analysis of Veterinary VaccineChapter 6 Veterinary Vaccine Market Competition Status by Major ManufacturersChapter 7 Veterinary Vaccine Major Manufacturers Introduction and Market DataChapter 8 Upstream and Downstream Market Analysis of Veterinary VaccineChapter 9 Cost and Gross Margin Analysis of Veterinary VaccineChapter 10 Marketing Status Analysis of Veterinary VaccineChapter 11 Report ConclusionChapter 12 Research Methodology and Reference Buy Veterinary Vaccine Market analysis & forecast 2018-2023 Report along with complete TOC @ https://www.upmarketresearch.com/buy/veterinary-vaccine-market “Veterinary Vaccine Market Analysis and Forecast 2018-2023” report helps the clients to take business decisions and to understand strategies of major players in the industry.
Global Veterinary Vaccine Market research report includes specific segments by region (country), by company, by Type and by Application.
This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
Understanding the segments helps in identifying the importance of different factors that aid the market growth.Segment by Type Live Attenuated VaccinesInactivated VaccinesOthersReport Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-veterinary-vaccine-2021-227 Segment by Application LivestockSwineChickenDog & CatOthersBy Region North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaGreeceUkraineMoldovaAlbaniaSerbiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaTaiwanIndonesiaThailandMalaysiaPhilippinesVietnamLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaU.A.EEgyptSouth AfricaIsraelKuwaitIranBy Company MerckZoetisBoehringer IngelheimCevaCAHICHVRIRingpu BiologyYebioDHNWINSUNElancoVirbacJinyu Bio-TechnologyChengDu TecbondCAVACKyoto Biken LaboratoriesFATROVaksindoBio-LabsAvimex Animal HealthMEVACBiovacAtafenDyntecBioTestLabRVSRIMedionGet the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-veterinary-vaccine-2021-227CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/24-market-reports
The latest trending report Global Veterinary Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The Veterinary Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Veterinary Vaccine industry, involving potential opportunity and challenges, drivers and risks.
We present the impact assessment of Covid-19 effects on Veterinary Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.
).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/16098-veterinary-vaccine-market-analysis-reportThe major players covered in Veterinary Vaccine are:MerckRingpu BiologyBoehringer IngelheimZoetisHVRIMerial/SanofiDHNCAHICCevaYebioChengDu TecbondFATROWINSUNBio-LabsCAVACJinyu Bio-TechnologyElanco/Eli LillyVaksindoKyoto BikenVirbacAvimex AnimalBy Type, Veterinary Vaccine market has been segmented intoLive Attenuated VaccinesInactivated VaccinesDNA VaccinesOtherBy Application, Veterinary Vaccine has been segmented into:LivestockSwineChickenDog & CatOtherThe report offers in-depth assessment of the growth and other aspects of the Veterinary Vaccine market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Veterinary Vaccine Market @ https://www.decisiondatabases.com/contact/download-sample-16098The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Veterinary Vaccine product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Veterinary Vaccine, with price, sales, revenue and global market share of Veterinary Vaccine in 2018 and 2019.Chapter 3, the Veterinary Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Veterinary Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Veterinary Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Veterinary Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Veterinary Vaccine Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16098All Vaccine Related Reports by DecisionDatabases.com @ https://goo.gl/Q2GmDtAbout-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Peptides have a variety of structures, including chain polypeptides, cyclic peptides, etc., but because chain polypeptides are too flexible, they can be twisted and flipped at will, making them too loose to make medicines well.
Classic peptide drugs are made from human hormones, natural toxin peptides or antibiotics as the basic skeleton, and then modified by appropriate chemical modifications (including the use of unnatural amino acids, fatty acid side chain modifications, etc.).
However, since traditional polypeptide molecules are mostly derived from human hormones or natural animal and plant extraction, the target is limited and the research and development efficiency is low.
Therefore, new research and development platforms with ultra-high capacity synthetic peptide libraries and high-throughput screening technologies have begun to develop rapidly.
Currently, the screening methods for synthetic peptide libraries include OBOC (one-bead-one-compound) library screening, phage display, mRNA display, and SICLOPPS (split-intein circular ligation of peptides and proteins) methods.
Among them, the phage display platform is represented by the technology platform of Bicycle Therapeutics.
Global Veterinary Vaccine market expansion is being boosted by the fast-rising demand income, decreasing industrialization, product recognition among consumers, emerging technological advancements market businesses, and structure that is secure.
The industry is reporting briskly raising revenue growth combined with sales volume.
Growth-drivers are anticipated to add notable growth into the market in the not-too-distant future.Key Player Mentioned: Merck, Yebio, Ceva, Zoetis, Ringpu Biology, Boehringer Ingelheim, WINSUN, HVRI, CAHIC, DHN, CAVAC, Vaksindo, Elanco, Avimex Animal Health, Kyoto Biken Laboratories, ChengDu Tecbond, Virbac, Bio-Labs, FATRO, Jinyu Bio-Technology, Medion, MEVAC, RVSRI, BioTestLab, Dyntec, Biovac, AtafenFor Right Perspective & Competitive Insights, Request a Sample @:https://www.imrmarketreports.com/request/17249The study needed to concentrate on Leading manufacturers environments, and analysis for its market that is Keyword.
The researchers focused on development tendencies in addition to the sector.
Additionally, the marketplace is anticipated to quicken alliances which are implemented across the globe as a result of exponential need for Veterinary Vaccine over companies and businesses.Product Segment Analysis: Live Attenuated Vaccines, Inactivated Vaccines, OthersApplication Segment Analysis: Livestock, Swine, Chicken, Dog & Cat, OthersRegional Segment Analysis: North America, Europe, Asia Pacific, Latin America, and Mideast and Africa.Regional evaluation is yet another highly vast region of the research and analysis study of the Global Veterinary Vaccine Market presented in the report.
The historical and forecast period 2020 to 2026 gives accurate and detailed country-wise quantity evaluation along with region-wise market size analysis from their worldwide Veterinary Vaccine marketplace.Get Up to 20% offGet Discount on Full Report of Veterinary Vaccine Market @: https://www.imrmarketreports.com/discount/17249This record provides a comprehensive Summary of a company profile of players and international Market's arena.
